Prosecution Insights
Last updated: November 04, 2026

Recce Pharmaceuticals Ltd.

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Recce Pharmaceuticals Ltd. currently holds a patent portfolio with 1 pending office action in the Chemistry & Materials technology area. This single active matter is being reviewed by 1 distinct examiner, HUHN, RICHARD A, who is also the busiest examiner with 1 busiest examiner pending action. The prosecution is concentrated within 1 distinct art unit, reflecting a narrow technical focus for the company's current USPTO filings.

Practitioners should recognize that having 1 pending office action under 1 distinct examiner creates a singular focus for the portfolio's current efforts. HUHN, RICHARD A is the sole individual responsible for the 1 busiest examiner pending action, meaning his specific preferences will dictate the immediate results in the Chemistry & Materials area. The matching count of 1 pending office action and 1 distinct examiner within 1 distinct art unit simplifies the tracking of deadlines and examiner interviews. However, this lack of examiner variety means the company cannot test different arguments across multiple files. The outcome of this 1 pending office action will define the company's standing at the USPTO for this technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUHN, RICHARD A 1 67.2% +5.5%

Top Art Units

Art UnitApps
1764 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17871164 PROCESS FOR PREPARATION OF BIOLOGICALLY ACTIVE COPOLYMER HUHN, RICHARD A 1764 §103 Final Rejection 49d Pending Jul 22, 2022

Managing Recce Pharmaceuticals Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Recce Pharmaceuticals Ltd. have?

Recce Pharmaceuticals Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Recce Pharmaceuticals Ltd. applications?

Richard A Huhn has the most, with 1 of Recce Pharmaceuticals Ltd.'s pending office actions.

What technology area are Recce Pharmaceuticals Ltd.'s patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month